[loeg]

Novo Nordisk's market cap is $500 B, mostly on the basis of GLP-1 drug profits, and the US' entire discretionary budget is $1,700 B. Even if Denmark would allow the sale, and even if somehow the US did not need to pay a premium to shareholders (typical in acquisitions), that would still be a very substantial expenditure.

[rsync]

The correct unit of measurement here is Iraq wars.

Purchasing NN Would cost roughly 0.2 Iraq wars.

[rustcleaner]

That is a sensible unit.

[bearjaws]

This ignores the fact that the patents expire in 5-7 years, GLP1 is (relatively) trivial to produce and will be a $100 generic by 2032.

[adventured]

That's not the way to go about it at all.

The EU loves to ransom US tech companies for budget money. It's very clear that this is an opportunity for the US to similarly damage a big EU company by threatening its patents in the US, or otherwise hitting Novo for tens of billions of dollars in ransom money. The US market is by a huge margin the most important drug market in the world, and especially for Novo.

Find an abusive excuse to invalidate their patents if all else fails. Let Europe learn a valuable lesson in trade wars.

[balthigor]

At this point in time, you are in no position to be teaching any lessons to the rest of the world, other than cautionary tales of wasted potential and the self-inflicted wounds of a belligerent populace.

[throwup238]

Voting majority is also controlled by the Novo Nordisk Foundation. It's already the wealthiest foundation on the planet so they're unlikely to give up their flagship enterprise.

[rustcleaner]

Not to be that guy but obesity is arguably kind-of a national security emergency thing...